myBIO Community - Biotechnology connections
Scientific & Biotech Conferences - Scientific Press Coverage at Leaders in Pharmaceutical Business Intelligence
Angel investors (not venture capital firms) are the most likely candidates to get your businesses from a piece of paper to a proof-of-concept. These angel investors typically come in four distinct groups: Friends and Family Friends and family...
Director of Web and New Media at Biotechnology Industry Organization
"There are fundamental scientific considerations at the heart of the larger debate regarding biosimilars. Distinguishable names for biological products developed by different manufacturers must be required to prevent inappropriate substitution, ...
Executive Director, Genetics Policy Institute (GPI); Founder & Chair, World Stem Cell Summit- 5,000+ contacts
Hon. Henry Cisneros (Leadership), Japanese Society for Regenerative Medicine (International Leadership), Mostyn Foundation (Advocacy), Texans for Stem Cell Research (Education), Huntington's Disease Advocacy Community (Inspiration). Awards to be ...
GPI's "Stem Cell Action Award" Honorees Announced globenewswire.com
SAN ANTONIO, TX, TEXAS, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Five honorees have been selected for the
Web Manager at Biotechnology Industry Organization
How successful has the JOBS Act been? 110 IPOs among biotechnology companies alone!
Since its passage more than two years ago, the Jumpstart Our Business Startups (JOBS) Act, which was designed to decrease regulatory burdens for raising capital, has spurred more than 110 IPOs among biotechnology companies alone. These are companies...
FDA Grants Merck Accelerated Approval for Keytruda (Pembrolizumab) for the Treatment of Patients With Inoperable or Metastatic Melanoma...
Publisher and Editor-Future Oncology and New Medicine's Oncology KnowledgeBASE (nmok.net)
In September 2014, the FDA granted accelerated approval to Keytruda (pembrolizumab) dosed at 2 mg/kg every 3 weeks for the treatment of patients with inoperable or metastatic melanoma that progressed following administration of ipilimumab and, if ...
Special Reports and Additional News nmok.net
New Medicine's OncologyKnowledgeBASE is a comprehensive source of information on the treatment of cancer and its complications for biotechnology, pharmaceutical, and financial institutions.
Chief Editor - Life Science Leader Magazine
Last week, the Biotechnology Industry Organization (BIO) invited biotechnology, pharmaceutical, business development, life sciences and policy...
California biopharma company Amarantus BioScience pioneers new blood-based tests for diagnosing Alzheimer's and Parkinson's, as well as...
Senior Research Writer at Crystal Research Associates, LLC
This morning's report details pipeline development, business model, growth strategies, market opportunities, potential milestones, competitive landscape, financial position, business risks, etc. for Amarantus BioScience Holdings, Inc. | http://hu ...
Crystal Research Associates initiates coverage of Amarantus BioScience Holdings (AMBS-OTC) with the release of a 76-page Executive Informational Overview.